Lupin Limited 7-142, M.I.D.C. Tarapur Via Boisar

FDA inspection history across 2 sites, 2019 to 2022

2
Form 483s
1
Warning letter

Every document, by year

  • Warning letter
  • Form 483

2019: one Form 483; 2022: one warning letter and one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2019One Form 483, at Tarapur, India.
  2. 2022One warning letter and one Form 483, at Palghar, India and Tarapur, India.
  3. 2022The longest 483 on file: 4 observations over 8 pages at Tarapur, India.

Cited most

Across all Lupin Limited 7-142, M.I.D.C. Tarapur Via Boisar observations on file

The complete Lupin Limited 7-142, M.I.D.C. Tarapur Via Boisar file.

All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$297

The price of the documents, added to your cart together

Sites

Documents

3 on file, newest first
DateDocumentPrice
2022-09-27Warning letter Warning letter$99
2022-04-04483 Form 483$99
2019-09-20483 Form 483$99

Investigators on these documents

Unnee Ranjan (1)

FEI number 3002807512 · most recent document Sep 27, 2022

About Lupin Limited 7-142, M.I.D.C. Tarapur Via Boisar

How many FDA Form 483s has Lupin Limited 7-142, M.I.D.C. Tarapur Via Boisar received?

FDA Intel has 2 Form 483s on file for Lupin Limited 7-142, M.I.D.C. Tarapur Via Boisar; the most recent is dated Apr 4, 2022.

When was Lupin Limited 7-142, M.I.D.C. Tarapur Via Boisar last inspected by FDA?

The most recent FDA inspection document on file for Lupin Limited 7-142, M.I.D.C. Tarapur Via Boisar is a Form 483 dated Apr 4, 2022, for the site in Tarapur, India.

What did FDA cite at Lupin Limited 7-142, M.I.D.C. Tarapur Via Boisar?

The regulations cited most in the observations on file for Lupin Limited 7-142, M.I.D.C. Tarapur Via Boisar are 21 CFR 211.192 (Production record review), 2 times; 21 CFR 211.67 (Equipment cleaning and maintenance), 2 times; 21 CFR 211.100 (Written procedures; deviations), 1 time.

Has Lupin Limited 7-142, M.I.D.C. Tarapur Via Boisar received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for Lupin Limited 7-142, M.I.D.C. Tarapur Via Boisar; the most recent is dated Sep 27, 2022.